article thumbnail

EU expands accessibility of product information for medicines with electronic format

Hospital Pharmacy Europe

Electronic product information (ePI) for selected human medicines has been published for the first time by the Heads of Medicines Agencies (HMA), the European Commission (EC) and the European Medicines Agency (EMA). According to the EMA, outcomes will inform how to integrate the ePIs into common practice and expand their use across the EU.

article thumbnail

Drug safety update says fluoroquinolone antibiotics should be last resort

Hospital Pharmacy Europe

Reports of serious adverse reactions to fluoroquinolone antibiotics have included tendinitis or tendon rupture, muscle pain, muscle weakness, joint pain, joint swelling, peripheral neuropathy and central nervous system effects. Fluoroquinolones use should be discontinued at the first signs of a serious adverse reaction.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

FDA reviewers back Pfizer/BioNTech COVID-19 vaccine ahead of panel

pharmaphorum

Pfizer and BioNTech are asking for an Emergency Use Authorization of their vaccine based on phase 3 data, which can be converted into a full licence at a later date once further trial information is published. of participants. of participants.

Vaccines 111
article thumbnail

Allergic reactions prompt Moderna COVID vaccine pause in California

pharmaphorum

According to state epidemiologist Dr Erica Pan, there were a higher-than-expected number of suspected allergic reactions at a community clinic being used to administer the shot, with some people needing medical attention in a 24-hour period.

Vaccines 136
article thumbnail

Important information about Dupixent and vaccines

The Checkup by Singlecare

For example, a recent study comparing the effects of COVID-19 vaccination on people with atopic dermatitis “found no significant difference in adverse reactions between the people taking Dupixent and the people taking other common eczema medications,” notes Dr. Yadav. But so far, the evidence is positive.

article thumbnail

mRNA vaccine trial shows efficiency in older adults with RSV

European Pharmaceutical Review

To date, most solicited adverse reactions were mild or moderate. The most commonly reported solicited adverse reactions in the mRNA-1345 group were injection site pain, fatigue, headache, myalgia, and arthralgia.

Vaccines 105
article thumbnail

Innovative biologic for myasthenia gravis granted European approval

European Pharmaceutical Review

This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. The post Innovative biologic for myasthenia gravis granted European approval appeared first on European Pharmaceutical Review.